Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages

EMBO Journal

Volumn 30, Issue 3, 2011, Pages 494-509

  Palii, Carmen G ^a   Perez Iratxeta, Carolina ^a   Yao, Zizhen ^b   Cao, Yi ^b   Dai, Fengtao ^a,c   Davison, Jerry ^b   Atkins, Harold ^a   Allan, David ^a   Dilworth, F Jeffrey ^a,c   Gentleman, Robert ^b   Tapscott, Stephen J ^b   Brand, Marjorie ^a,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

erythroid cells; ETS1; RUNX1; SCL TAL1; T cell acute lymphoblastic leukaemia (T ALL)

Indexed keywords

CD69 ANTIGEN; CYCLIN DEPENDENT KINASE 6; POLO LIKE KINASE 3; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR TAL1;

ARTICLE; BINDING SITE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ERYTHROID CELL; GENE EXPRESSION PROFILING; GENE SEQUENCE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

EID: 79551605803     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.342     Document Type: Article

References (68)

1. Aho TL, Sandholm J, Peltola KJ, Ito Y, Koskinen PJ (2006) Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell Biol 7: 21
2. Aifantis I, Raetz E, Buonamici S (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8: 380-390
3. Aliahmad P, Kaye J (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205: 245-256
4. Anderson MK (2006) At the crossroads: diverse roles of early thymocyte transcriptional regulators. Immunol Rev 209: 191-211
5. Begley CG, Green AR (1999) The SCL gene: from case report to critical hematopoietic regulator. Blood 93: 2760-2770
6. Bendelac A, Matzinger P, Seder RA, Paul WE, Schwartz RH (1992) Activation events during thymic selection. J Exp Med 175: 731-742
7. Bernard M, Delabesse E, Smit L, Millien C, Kirsch IR, Strominger JL, Macintyre EA (1998) Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers. Int Immunol 10: 1539-1549
8. Blyth K, Cameron ER, Neil JC (2005) The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 5: 376-387
9. Brunet de la Grange P, Armstrong F, Duval V, Rouyez MC, Goardon N, Romeo PH, Pflumio F (2006) Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood 108: 2998-3004
10. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ (2010) Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 18: 662-674
11. Chang PY, Draheim K, Kelliher MA, Miyamoto S (2006) NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells. Cancer Res 66: 6008-6013
12. Chaturvedi CP, Hosey AM, Palii C, Perez-Iratxeta C, Nakatani Y, Ranish JA, Dilworth FJ, Brand M (2009) Dual role for the methyltransferase G9a in the maintenance of {beta}-globin gene transcription in adult erythroid cells. Proc Natl Acad Sci USA 106: 18303-18308
13. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T, King DC, Chen KB, Zhang Y, Drautz D, Giardine B, Schuster SC, Miller W, Chiaromonte F, Blobel GA, Weiss MJ, Hardison RC (2009) Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19: 2172-2184
14. Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C, Benedetti A, Vinante F, Pizzolo G, Inghirami G (1998) Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol 152: 209-217
15. Condorelli GL, Facchiano F, Valtieri M, Proietti E, Vitelli L, Lulli V, Huebner K, Peschle C, Croce CM (1996) T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res 56: 5113-5119
16. Fang L, Zhang X, Miao J, Zhao F, Yang K, Zhuang R, Bujard H, Wei Y, Yang A, Chen L, Jin B (2009) Expression of CD226 antagonizes apoptotic cell death in murine thymocytes. J Immunol 182: 5453-5460
17. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TR, Look AT (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1: 75-87
18. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA, Choi K, Farnham PJ, Bresnick EH (2009) Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 36: 667-681
19. Gallant S, Gilkeson G (2006) ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz) 54: 149-163
20. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, Marden MC, Wajcman H, Douay L (2005) Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 23: 69-74
21. Grossel MJ, Hinds PW (2006) Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 97: 485-493
22. Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, Larson R, Zhang J, Protopopov A, Chin L, Pandolfi PP, Silverman LB, Hunger SP, Sallan SE, Look AT (2009) High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 114: 647-650
23. Hollenhorst PC, Chandler KJ, Poulsen RL, Johnson WE, Speck NA, Graves BJ (2009) DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet 5: e1000778
24. Hollenhorst PC, Jones DA, Graves BJ (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32: 5693-5702
25. Hsu HL, Huang L, Tsan JT, FunkW,Wright WE, Hu JS, Kingston RE, Baer R (1994) Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14: 1256-1265
26. Hu MG, Deshpande A, Enos M, Mao D, Hinds EA, Hu GF, Chang R, Guo Z, Dose M, Mao C, Tsichlis PN, Gounari F, Hinds PW (2009) A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res 69: 810-818
27. Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A (2000) Deathassociated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 20: 1044-1054
28. Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, Green AL, Vyas P, Porcher C (2010) Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res 20: 1064-1083
29. Kawase T, Ichikawa H, Ohta T, Nozaki N, Tashiro F, Ohki R, Taya Y (2008) p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis. Oncogene 27: 3797-3810
30. Kelliher MA, Seldin DC, Leder P (1996) Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J 15: 5160-5166
31. Lacombe J, Herblot S, Rojas-Sutterlin S, Haman A, Barakat S, Iscove NN, Sauvageau G, Hoang T (2010) Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 115: 792-803
32. Lahlil R, Lecuyer E, Herblot S, Hoang T (2004) SCL assembles a multifactorial complex that determines glycophorin A expression. Mol Cell Biol 24: 1439-1452
33. Landry JR, Bonadies N, Kinston S, Knezevic K, Wilson NK, Oram SH, Janes M, Piltz S, Hammett M, Carter J, Hamilton T, Donaldson IJ, Lacaud G, Frampton J, Follows G, Kouskoff V, Gottgens B (2009) Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors. Blood 113: 5783-5792
34. Lecuyer E, Herblot S, Saint-Denis M, Martin R, Begley CG, Porcher C, Orkin SH, Hoang T (2002) The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 100: 2430-2440
35. Lecuyer E, Hoang T (2004) SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 32: 11-24
36. Lee MS, Hanspers K, Barker CS, Korn AP, McCune JM (2004) Gene expression profiles during human CD4+ Tcell differentiation. Int Immunol 16: 1109-1124
37. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
38. Malynn BA, Ma A (2009) A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J Exp Med 206: 977-980
39. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, Gonzales E, Wu P, Neben S, Georgopoulos K (1997) Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J 16: 2004-2013
40. Muthusamy N, Barton K, Leiden JM (1995) Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377: 639-642
41. O'Neil J, Look AT (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26: 6838-6849
42. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53- induced apoptosis. Science 288: 1053-1058
43. Ono Y, Fukuhara N, Yoshie O (1998) TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol 18: 6939-6950
44. Palomero T, Dominguez M, Ferrando AA (2008) The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 7: 965-970
45. Palomero T, Odom DT, O'Neil J, Ferrando AA, Margolin A, Neuberg DS, Winter SS, Larson RS, Li W, Liu XS, Young RA, Look AT (2006) Transcriptional regulatory networks downstream of TAL1/ SCL in T-cell acute lymphoblastic leukemia. Blood 108: 986-992
46. Pan Y, Tsai CJ, Ma B, Nussinov R (2009) How do transcription factors select specific binding sites in the genome? Nat Struct Mol Biol 16: 1118-1120
47. Quong MW, Romanow WJ, Murre C (2002) E protein function in lymphocyte development. Annu Rev Immunol 20: 301-322
48. Reynaud D, Ravet E, Titeux M, Mazurier F, Renia L, Dubart- Kupperschmitt A, Romeo PH, Pflumio F (2005) SCL/TAL1 expression level regulates human hematopoietic stem cell selfrenewal and engraftment. Blood 106: 2318-2328
49. Sacchi N, de Klein A, Showalter SD, Bigi G, Papas TS (1988) High expression of ets-1 gene in human thymocytes and immature T leukemic cells. Leukemia 2: 12-18
50. Sancho D, Gomez M, Sanchez-Madrid F (2005) CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26: 136-140
51. Schilham MW, Moerer P, Cumano A, Clevers HC (1997) Sox-4 facilitates thymocyte differentiation. Eur J Immunol 27: 1292-1295
52. Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19: 621-626
53. Schwartz R, Engel I, Fallahi-Sichani M, Petrie HT, Murre C (2006) Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc Natl Acad Sci USA 103: 9976-9981
54. Soler E, Andrieu-Soler C, de Boer E, Bryne JC, Thongjuea S, Stadhouders R, Palstra RJ, Stevens M, Kockx C, van Ijcken W, Hou J, Steinhoff C, Rijkers E, Lenhard B, Grosveld F (2010) The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev 24: 277-289
55. Song SH, Hou C, Dean A (2007) A positive role for NLI/Ldb1 in long-range beta-globin locus control region function. Mol Cell 28: 810-822
56. Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA (2009) Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 4: 180-186
57. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550
58. Tenen DG (2003) Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 3: 89-101
59. Ting CN, Olson MC, Barton KP, Leiden JM (1996) Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384: 474-478
60. Tripic T, Deng W, Cheng Y, Zhang Y, Vakoc CR, Gregory GD, Hardison RC, Blobel GA (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113: 2191-2201
61. Vyas P, McDevitt MA, Cantor AB, Katz SG, Fujiwara Y, Orkin SH (1999) Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126: 2799-2811
62. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16: 3145-3157
63. Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT (2005) Tal1/ SCL binding to pericentromeric DNA represses transcription. J Biol Chem 280: 12956-12966
64. Wilson NK, Foster SD, Wang X, Knezevic K, Schutte J, Kaimakis P, Chilarska PM, Kinston S, Ouwehand WH, Dzierzak E, Pimanda JE, de Bruijn MF, Gottgens B (2010) Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7: 532-544
65. Wilson NK, Miranda-Saavedra D, Kinston S, Bonadies N, Foster SD, Calero-Nieto F, Dawson MA, Donaldson IJ, Dumon S, Frampton J, Janky R, Sun XH, Teichmann SA, Bannister AJ, Gottgens B (2009) The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 113: 5456-5465
66. Xie S, Wu H, Wang Q, Cogswell JP, Husain I, Conn C, Stambrook P, Jhanwar-Uniyal M, Dai W (2001) Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 276: 43305-43312
67. Xu Z, Huang S, Chang LS, Agulnick AD, Brandt SJ (2003) Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol 23: 7585-7599
68. Zenklusen JC, Conti CJ, Green ED (2001) Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet 27: 392-398